Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Mersana Therapeutics (MRSN) Insider Trading & Ownership

Mersana Therapeutics logo
$7.42 +0.61 (+8.96%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$7.49 +0.07 (+1.00%)
As of 08/14/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Mersana Therapeutics (NASDAQ:MRSN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$153.93K
Get MRSN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mersana Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MRSN Insider Buying and Selling by Quarter

Mersana Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/16/2025Anna ProtopapasDirectorSell345$14.50$5,002.50  
1/16/2025Ashish MandeliaCAOSell142$14.50$2,059.00  
1/16/2025Martin H Jr. HuberCEOSell180$14.50$2,610.00  
1/16/2025Timothy B LowingerSVPSell321$14.50$4,654.50  
1/14/2025Anna ProtopapasDirectorSell461$16.50$7,606.50  
1/14/2025Ashish MandeliaCAOSell40$16.50$660.00  
1/14/2025Timothy B LowingerSVPSell139$16.50$2,293.50  
10/28/2024Mohan BalaSVPSell75$47.50$3,562.50  
10/3/2024Alejandra CarvajalSVPSell223$49.00$10,927.00  
10/2/2024Ashish MandeliaCAOSell194$50.00$9,700.00  
10/2/2024Brian DeschuytnerCFOSell323$50.00$16,150.00  
9/12/2024Martin H Jr. HuberCEOSell2,016$44.00$88,704.00  
(Data available from 1/1/2013 forward)

MRSN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Mersana Therapeutics includes Alejandra Carvajal, Anna Protopapas, Arvin Yang, Ashish Mandelia, Brian Deschuytner, Martin H Jr. Huber, Mohan Bala, Timothy B Lowinger, and Tushar Misra. Learn more on insiders at MRSN.

13.00% of Mersana Therapeutics stock is owned by insiders. Learn more on MRSN's insider holdings.

The following insiders have sold MRSN shares in the last 24 months: Alejandra Carvajal ($10,927.00), Anna Protopapas ($92,215.25), Ashish Mandelia ($26,036.75), Brian Deschuytner ($41,420.75), Martin H Jr. Huber ($91,314.00), Mohan Bala ($5,709.50), Timothy B Lowinger ($6,948.00), and Tushar Misra ($11,320.50).

Insiders have sold a total of 6,494 Mersana Therapeutics shares in the last 24 months for a total of $285,891.75 sold.

Mersana Therapeutics Key Executives

  • Dr. Martin H. Huber M.D. (Age 63)
    President, CEO & Director
    Compensation: $44k
  • Mr. Brian C. DeSchuytner (Age 45)
    Senior VP, CFO & COO
    Compensation: $626.32k
  • Dr. Timothy B. Lowinger Ph.D. (Age 60)
    Senior VP and Chief Science & Technology Officer
    Compensation: $666.3k
  • Ms. Alejandra Veronica Carvajal J.D. (Age 50)
    Senior VP, Secretary & Chief Legal Officer
    Compensation: $606.51k
  • Mr. Mikhail Papisov Ph.D.
    Co-Founder
  • Mr. Ashish MandeliaMr. Ashish Mandelia (Age 49)
    VP, Controller & Chief Accounting Officer
  • Mr. Jason Fredette
    Senior Vice President of Investor Relations & Corporate Communications
  • Mr. Chuck Miller
    Senior Vice President of Regulatory Affairs
  • Mr. Marc Damelin
    Exe. Director and Head of Biology, Oncology, Antibody-Drug Conjugate ADC Discovery & Develop.
  • Dr. Tushar Misra Ph.D. (Age 63)
    Senior VP & Chief Manufacturing Officer
    Compensation: $485.89k

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:MRSN) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored